We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
41 hedge funds and large institutions have $229M invested in Evelo Biosciences, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
55% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 11
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
3% more funds holding
Funds holding: 40 → 41 (+1)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less capital invested
Capital invested by funds: $366M → $229M (-$138M)
Holders
41
Holders Change
+1
Holders Change %
+2.5%
% of All Funds
0.89%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
5
Increased
17
Reduced
11
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$245K |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$235K |
| 3 |
Goldman Sachs
New York
|
-$156K |
| 4 |
PCM
Prelude Capital Management
New York
|
-$112K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$63.2K |
